GreenAngel to assist Mazza Innovation in bio-based chemicals financing, commercialization

In Canada, GreenAngel has entered into an advisory agreement to assist Mazza Innovation in its corporate finance and technology commercialization activities in exchange for up to 480,000 Mazza shares, representing approximately 10% of the issued shares in the company.

Mazza is developing a novel pressurized low polarity water extraction technology to acquire high-value phytochemicals from plants that can be incorporated into products such as foods, pharmaceuticals and cosmetics.  GreenAngel is leading an initial financing round, to total $300,000, including an initial commitment of $100,000 combined from GreenAngel Technology Ventures and WUTIF Capital.